Publications by authors named "Suzanne Shoemaker"

Claim this Profile
T
Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer.
Chang Liu, Tatiana Shaurova, Suzanne Shoemaker, Martin Petkovich, Pamela A Hershberger

Mol Pharm· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
Alissa R Verone-Boyle, Suzanne Shoemaker, Kristopher Attwood, Carl D Morrison, Andrew J Makowski

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment.
Santosh Kumar Upadhyay, Alissa Verone, Suzanne Shoemaker, Maochun Qin, Song Liu

Cancers (Basel)· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.
Qiuhong Zhang, Beatriz Kanterewicz, Suzanne Shoemaker, Qiang Hu, Song Liu

J Steroid Biochem Mol Biol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice.
Mary Ann Warren, Suzanne F Shoemaker, David J Shealy, Wiam Bshar, Margot M Ip

Mol Cancer Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways.
Xiaojing Meng, Suzanne F Shoemaker, Sibel O McGee, Margot M Ip

Carcinogenesis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium.
Margot M Ip, Sibel O McGee, Patricia A Masso-Welch, Clement Ip, Xiaojing Meng, Suzanne F Shoemaker

Carcinogenesis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.
Jiping Zhang, Mary Ann Warren, Suzanne F Shoemaker, Margot M Ip

Endocrinology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature.
Patricia A Masso-Welch, Danilo Zangani, Clement Ip, Mary M Vaughan, Suzanne F Shoemaker

J Nutr· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Patricia A Masso-Welch, Danilo Zangani, Clement Ip, Mary M Vaughan, Suzanne Shoemaker

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis